Name: Streptococcus pneumoniae Jorgensen 262
Creator: BacDive
License: https://creativecommons.org/licenses/by/4.0/

Strain identifier

BacDive ID: 14750

Type strain:

Species: Streptococcus pneumoniae

Strain Designation: Jorgensen 262, 262

Culture col. no.: DSM 24048, ATCC 49619, CCM 4501, CCUG 33638, DSM 11967, LMG 15155, CIP 104340, NCTC 12977

Strain history: CIP <- 1995, ATCC <- J.H. Jorgensen: strain 262 <- M. Saubolle

NCBI tax ID(s): 1313 (species)

SI-ID 7827

LMG 15155, ATCC 49619, CCM 4501, CCUG 33638, CIP 104340, NCTC 12977, DSM 11967, CNCTC 5043, LMG 21598, BCRC 16014, CCRC 16014, CECT 8737, DSM 24048

Special Collections

Other strains from Streptococcus pneumoniae

Section

Streptococcus pneumoniae Jorgensen 262 is a microaerophile, Gram-positive, coccus-shaped human pathogen that has multiple antibiotic resistances and was isolated from human sputum, 75-year-old male.

antibiotic resistance
coccus-shaped
Gram-positive
human pathogen
microaerophile
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacillota*
	Class	*Bacilli*
	Order	*Lactobacillales*
	Family	*Streptococcaceae*
	Genus	*Streptococcus*
	Species	**Streptococcus pneumoniae**
	Full Scientific Name (LPSN)	Streptococcus pneumoniae (Klein 1884) Chester 1901 (Approved Lists 1980)

	Synonym	"Staphylococcus* pneumoniae"*
	Synonym	"Micrococcus* pneumoniae"*

Information on morphological and physiological properties Morphology

[Ref.: #121897]	Gram stain	positive

[Ref.: #121897]	Cell shape	coccus-shaped

[Ref.: #121897]	Motility	no
[Ref.: #69480]	Motility	no Confidence in %90.479

[Ref.: #17316]	Type of hemolysis	alpha
[Ref.: #17316]	Hemolysis ability	1
[Ref.: #17316]	Incubation period	1-2 days

[Ref.: #121897]	Hemolysis ability	1

Information on culture and growth conditions Culture and growth conditions

[Ref.: #17316]

Culture medium

TODD-HEWITT MEDIUM (DSMZ Medium 697)

[Ref.: #17316]

Culture medium growth

[Ref.: #17316]

Culture medium link

Medium recipe at MediaDive

[Ref.: #17316]

Culture medium composition

expand / minimize

[Ref.: #17316]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #17316]

Culture medium growth

[Ref.: #17316]

Culture medium link

Medium recipe at MediaDive

[Ref.: #17316]

Culture medium composition

expand / minimize

[Ref.: #17316]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #17316]

Culture medium growth

[Ref.: #17316]

Culture medium link

Medium recipe at MediaDive

[Ref.: #17316]

Culture medium composition

expand / minimize

[Ref.: #41690]

Culture medium

MEDIUM 6 - Columbia agar with 10 % horse blood

[Ref.: #41690]

Culture medium growth

[Ref.: #41690]

Culture medium composition

expand / minimize

[Ref.: #121897]

Culture medium

CIP Medium 6

[Ref.: #121897]

Culture medium growth

[Ref.: #121897]

Culture medium link

Medium recipe provided by DSMZ

	Kind of temperature		Temperature
[Ref.: #17316]		growth	37 °C
[Ref.: #41690]		growth	37 °C
[Ref.: #121897]		growth	30-37 °C
[Ref.: #121897]	no	growth	10 °C
[Ref.: #121897]	no	growth	45 °C

Information on physiology and metabolism Physiology and metabolism

[Ref.: #17316]	Oxygen tolerance	microaerophile
[Ref.: #121897]	Oxygen tolerance	facultative anaerobe

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Test 3

Test 4

Test 5

Test 6

Reference

[Ref.: #17316]
M 693
37

microaerophil
yes
Inhibition zone diameter in mm
24
18
30
26-28
30
28
28
30
resistant0
34
28
26-28
12
resistant0
20
28
22
16
16
resistant0
resistant0
24
22
resistant0
resistant0
resistant0
26
30
26-28
10-12
24
30
resistant0
20
18
28-30

[Ref.: #17316]
M 693
37
1
microaerophil
yes
Inhibition zone diameter in mm
28-30
22
34-36
32
32
32
32
36-38
resistant0
40
28-30
30
resistant0
10
20-22
30
26-28
16
12
resistant0
resistant0
26
26
resistant0
resistant0
resistant0
28-30
34
30-32
22
26
32-34
resistant0
20
20
30-32

[Ref.: #17316]
M 693
37
1
microaerophil
yes
Inhibition zone diameter in mm
30-32
22
34
32
30-32
30-32
30-32
36-38
resistant0
40
28-30
30
resistant0
10
22
30
26
16
16
resistant0
6
28
26
8
6
resistant0
28
36
30-32
26
22
30
resistant0
20
20
32

[Ref.: #17316]
M 693



yes
Inhibition zone diameter in mm
32-34
24
38
32-34
34
32-34
34
38-40
resistant0
40
30
30
12
6
22
30
28
16
14
resistant0
resistant0
30
26
resistant0
resistant0
resistant0
30
36
32-34
18
24
30
resistant0
20
20
32-34

[Ref.: #17316]
M 693
37

microaerophil
yes
Inhibition zone diameter in mm
24
18-20
30
26
28-30
26
26
30
resistant0
32
24
24-26
8
12-14
18
26
24
16-18
12
resistant0
resistant0
22-24
20
resistant0
8-10
6
22
30
26
20
20
26-28
resistant0
20
16
26-28

[Ref.: #17316]
M 693
37

microaerophil
yes
Inhibition zone diameter in mm
24
18-20
30
26
28-30
26
26
30
resistant0
32
24
24-26
8
12-14
18
26
24
16-18
12
resistant0
resistant0
22-24
20
resistant0
8-10
6
22
30
26
20
20
26-28
resistant0
20
16
26-28

Only first 15 entries are displayed. Click here to see all.

[Ref.: #69481]

Ability of spore formation

no Confidence in %100

	Halophily	Salt	Tested relation		Salt conc.
[Ref.: #121897]		NaCl	no	growth	6.5	%

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68381]	alpha-cyclodextrin ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68380]	arginine ChEBI	-	hydrolysis	* from API rID32A
[Ref.: #68381]	D-arabitol ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68381]	D-mannitol ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68380]	D-mannose ChEBI	-	fermentation	* from API rID32A
[Ref.: #68381]	D-ribose ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68381]	D-tagatose ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #121897]	esculin ChEBI	-	hydrolysis
[Ref.: #68381]	glycogen ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68381]	hippurate ChEBI	-	hydrolysis	* from API rID32STR
[Ref.: #68381]	L-arabinose ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68380]	L-glutamate ChEBI	-	degradation	* from API rID32A
[Ref.: #68381]	lactose ChEBI	+	builds acid from	* from API rID32STR
[Ref.: #68381]	melezitose ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #121897]	nitrate ChEBI	-	reduction
[Ref.: #68380]	nitrate ChEBI	-	reduction	* from API rID32A
[Ref.: #121897]	nitrite ChEBI	-	reduction
[Ref.: #68380]	raffinose ChEBI	-	fermentation	* from API rID32A
[Ref.: #68381]	sorbitol ChEBI	-	builds acid from	* from API rID32STR
[Ref.: #68381]	trehalose ChEBI	+	builds acid from	* from API rID32STR
[Ref.: #68380]	tryptophan ChEBI	-	energy source	* from API rID32A
[Ref.: #68380]	urea ChEBI	-	hydrolysis	* from API rID32A, API rID32STR
	Only first 10 entries are displayed. Click here to see all.

	Antibiotica	Metabolite	Antibiotic sensitivity	Antibiotic resistance
[Ref.: #121897]		optochin ChEBI	yes	no

	Metabolite	Production
[Ref.: #121897]	indole ChEBI	no
[Ref.: #68381]	acetoin ChEBI	no	* from API rID32STR
[Ref.: #68380]	indole ChEBI	no	* from API rID32A

	Metabolite	Voges-Proskauer-test	Indole test
[Ref.: #121897]	acetoin ChEBI	-
[Ref.: #68381]	acetoin ChEBI	-		* from API rID32STR
[Ref.: #68380]	indole ChEBI		-	* from API rID32A

	Enzyme	Enzyme activity	EC number
[Ref.: #68382]	acid phosphatase	+	3.1.3.2	* from API zym
[Ref.: #68380]	alanine arylamidase	+	3.4.11.2	* from API rID32A
[Ref.: #68381]	Alanyl-Phenylalanyl-Proline arylamidase	+		* from API rID32STR
[Ref.: #121897]	alcohol dehydrogenase	-	1.1.1.1
[Ref.: #68380]	alkaline phosphatase	-	3.1.3.1	* from API rID32A, API zym
[Ref.: #68380]	alpha-arabinosidase	-	3.2.1.55	* from API rID32A
[Ref.: #68382]	alpha-chymotrypsin	+	3.4.21.1	* from API zym
[Ref.: #68380]	alpha-fucosidase	-	3.2.1.51	* from API rID32A, API zym
[Ref.: #68381]	alpha-galactosidase	+	3.2.1.22	* from API rID32STR, API rID32A, API zym
[Ref.: #68380]	alpha-glucosidase	+	3.2.1.20	* from API rID32A, API zym
[Ref.: #68382]	alpha-mannosidase	-	3.2.1.24	* from API zym
[Ref.: #68380]	arginine dihydrolase	-	3.5.3.6	* from API rID32A
[Ref.: #121897]	beta-galactosidase	+	3.2.1.23
[Ref.: #68380]	beta-galactosidase	+	3.2.1.23	* from API rID32A
[Ref.: #68382]	beta-galactosidase	-	3.2.1.23	* from API zym
[Ref.: #68380]	beta-Galactosidase 6-phosphate	-		* from API rID32A
[Ref.: #68380]	beta-glucosidase	+	3.2.1.21	* from API rID32A
[Ref.: #68381]	beta-glucosidase	-	3.2.1.21	* from API rID32STR, API zym
[Ref.: #68381]	beta-glucuronidase	-	3.2.1.31	* from API rID32STR, API rID32A, API zym
[Ref.: #68381]	beta-mannosidase	-	3.2.1.25	* from API rID32STR
[Ref.: #17316]	catalase	-	1.11.1.6
[Ref.: #121897]	catalase	-	1.11.1.6
[Ref.: #68382]	cystine arylamidase	-	3.4.11.3	* from API zym
[Ref.: #17316]	cytochrome-c oxidase	-	1.9.3.1
[Ref.: #68382]	esterase (C 4)	+		* from API zym
[Ref.: #68382]	esterase lipase (C 8)	+		* from API zym
[Ref.: #68380]	glutamate decarboxylase	-	4.1.1.15	* from API rID32A
[Ref.: #68380]	glutamyl-glutamate arylamidase	-		* from API rID32A
[Ref.: #68380]	glycin arylamidase	-		* from API rID32A
[Ref.: #68381]	glycyl tryptophan arylamidase	+		* from API rID32STR
[Ref.: #68380]	histidine arylamidase	-		* from API rID32A
[Ref.: #68380]	L-arginine arylamidase	+		* from API rID32A
[Ref.: #68380]	leucine arylamidase	+	3.4.11.1	* from API rID32A, API zym
[Ref.: #68380]	leucyl glycin arylamidase	-	3.4.11.1	* from API rID32A
[Ref.: #68382]	lipase (C 14)	-		* from API zym
[Ref.: #121897]	lysine decarboxylase	-	4.1.1.18
[Ref.: #68380]	N-acetyl-beta-glucosaminidase	+	3.2.1.52	* from API rID32A, API zym
[Ref.: #68382]	naphthol-AS-BI-phosphohydrolase	-		* from API zym
[Ref.: #121897]	ornithine decarboxylase	-	4.1.1.17
[Ref.: #121897]	oxidase	-
[Ref.: #68380]	phenylalanine arylamidase	+		* from API rID32A
[Ref.: #68380]	proline-arylamidase	-	3.4.11.5	* from API rID32A
[Ref.: #68380]	pyrrolidonyl arylamidase	-	3.4.19.3	* from API rID32A
[Ref.: #68380]	serine arylamidase	+		* from API rID32A
[Ref.: #68382]	trypsin	-	3.4.21.4	* from API zym
[Ref.: #68380]	tryptophan deaminase	-	4.1.99.1	* from API rID32A
[Ref.: #68380]	tyrosine arylamidase	+		* from API rID32A
[Ref.: #121897]	urease	-	3.5.1.5
[Ref.: #68381]	urease	-	3.5.1.5	* from API rID32STR, API rID32A
[Ref.: #68382]	valine arylamidase	+		* from API zym
	Only first 10 entries are displayed. Click here to see all.

API® Biotype100:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
[Ref.: #121897]	642	not determinedn.d.	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

API® rID32A:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	alpha-Galactosidasealpha GAL	beta-Galactosidasebeta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha-Glucosidasealpha GLU	beta-Glucosidasebeta GLU	alpha-Arabinosidasealpha ARA	beta-Glucuronidasebeta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	Fermentation of D-mannoseMNE	Fermentation of raffinoseRAF	Glutamate decarboxylaseGDC	alpha-Fucosidasealpha FUC	Reduction of nitrateNIT	Indole productionIND	Alkaline phosphatasePAL	L-arginine arylamidaseArgA	Proline arylamidaseProA	Leucyl glycin arylamidaseLGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	Pyrrolidonyl arylamidasePyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
[Ref.: #51650]	4263	-	-	+	+	-	+	+	-	-	+	-	-	-	-	-	-	-	+	-	-	+	+	-	+	+	-	-	-	+

API® rID32STR:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Arginine dihydrolaseADH (Arg)	beta-Glucosidasebeta GLU	beta-Galactosidasebeta GAR	beta-Glucuronidasebeta GUR	alpha-Galactosidasealpha GAL	Alkaline PhosphatasePAL	Acid from D-riboseRIB	Acid from D-mannitolMAN	Acid from sorbitolSOR	Acid from lactoseLAC	Acid from trehaloseTRE	Acid from raffinoseRAF	Acid from sucroseSAC	Acid from L-arabinoseLARA	Acid from D-arabitolDARL	Acid from alpha-cyclodextrinCDEX	Acetoin production (Voges Proskauer test)VP	Alanyl-Phenylalanyl-Proline arylamidaseAPPA	beta-Galactosidasebeta GAL	Pyrrolidonyl arylamidasePyrA	N-Acetyl-glucosaminidasebeta NAG	Glycyl-tryptophan arylamidaseGTA	Hydrolysis of hippuric acidHIP	Acid from glycogenGLYG	Acid from pullulanPUL	Acid from maltoseMAL	Acid from melibioseMEL	Acid from melezitoseMLZ	Acidification of methyl beta-D-glucopyranosideMbeta DG	Acid from D-tagatoseTAG	beta-Mannosidasebeta MAN	Urease/urea hydrolysisURE
[Ref.: #17316]	10813	-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	-	-	+	+	-	-	+	+	+	-	-	-	-	-
[Ref.: #17316]	10735	+	-	+	-	+	+	-	-	-	+	+	+	+	-	-	-	-	+	+	+	+	+	-	-	+	+	+	-	+	-	-	-
[Ref.: #17316]	10574	-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	-	-	+	+	-	-	+/-	+/-	-	-	+/-	-	-	-
[Ref.: #17316]	10573	-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	+	-	+	+	-	-	+	+	-	-	-	-	-	-
[Ref.: #17316]	10572	-	-	+	-	+	-	-	-	-	+	+	+/-	+/-	-	-	-	-	+	-	-	+	+	-	-	+/-	+/-	-	-	-	-	-	-
[Ref.: #17316]	10571	-	-	+	-	+	+/-	-	-	-	+	+	+	+	-	-	-	-	+	+	+	+	+	-	-	-	-	-	-	-	-	-	-
[Ref.: #51650]	3627	-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	-	+	-	+	-	-	+	+	-	-	+	-	-	-
[Ref.: #17316]	10882	+/-	-	+	-	+	-	-	-	-	+	+	+	+	-	-	-	-	+	+	+	+	+	-	-	+	+	-	-	+	-	-	-

API® zym:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	2-naphthyl phosphateAlkaline phosphatase	2-naphthyl butyrateEsterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	2-naphthyl myristateLipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	N-benzoyl-DL-arginine-2-naphthylamideTrypsin	N-glutaryl-phenylalanine-2-naphthylamidealpha- Chymotrypsin	2-naphthyl phosphateAcid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	6-Br-2-naphthyl-alphaD-galactpyranosidealpha- Galactosidase	2-naphthyl-betaD-galactpyranosidebeta- Galactosidase	Naphthol-AS-BI-betaD-glucuronidebeta- Glucuronidase	2-naphthyl-alphaD-glucopyranosidealpha- Glucosidase	6-Br-2-naphthyl-betaD-glucopyranosidebeta- Glucosidase	1-naphthyl-N-acetyl-betaD-glucosaminideN-acetyl-beta- glucosaminidase	6-Br-2-naphthyl-alphaD-mannopyranosidealpha- Mannosidase	2-naphthyl-alphaL-fucopyranosidealpha- Fucosidase
[Ref.: #121897]	7897	-	-	+	+	-	+	+	-	-	+	+	-	+	-	-	+	-	+	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #17316]	Sample type/isolated from	human sputum, 75-year-old male
[Ref.: #17316]	Geographic location (country and/or sea, region)	Arizona, Phoenix
[Ref.: #17316]	Country	USA
[Ref.: #17316]	Country ISO 3 Code	USA
[Ref.: #17316]	Continent	North America
[Ref.: #17316]	Geographic location	33.4484°/-112.0740°

[Ref.: #51650]	Sample type/isolated from	Human sputum,75-year-old male
[Ref.: #51650]	Geographic location (country and/or sea, region)	Arizona,Phoenix
[Ref.: #51650]	Country	USA
[Ref.: #51650]	Country ISO 3 Code	USA
[Ref.: #51650]	Continent	North America

[Ref.: #121897]	Sample type/isolated from	Human, Sputum
[Ref.: #121897]	Geographic location (country and/or sea, region)	Phoenix, Arizona
[Ref.: #121897]	Country	United States of America
[Ref.: #121897]	Country ISO 3 Code	USA
[Ref.: #121897]	Continent	North America
* marker position based on {}

Isolation sources categories

#Host	#Human	#Male
#Host Body Product	#Fluids	#Sputum

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence EU156773 (>99% sequence identity) for Streptococcus from Microbeatlas

Aquatic Samples	1515
Soil Samples	819
Animal Samples	56551
Plant Samples	407
Total Samples	59292

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #17316]	Pathogenicity (human)	yes
[Ref.: #17316]	Pathogenicity (animal)	yes
[Ref.: #17316]	Biosafety level	2	Risk group (German classification) According to TRBA 466
[Ref.: #121897]	Biosafety level	2	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #20218]	Streptococcus pneumoniae strain ATCC 49619 16S ribosomal RNA gene, partial sequence; and 16S-23S ribosomal RNA intergenic spacer, complete sequence	AY347558	372	GenBank ENA	1313 tax ID	*
[Ref.: #20218]	Streptococcus pneumoniae strain ATCC 49619 16S ribosomal RNA gene, partial sequence	EU156773	1329	GenBank ENA	1313 tax ID	*
[Ref.: #20218]	Streptococcus pneumoniae ATCC 49619 16S ribosomal RNA gene, partial sequence	AY281082	1428	GenBank ENA	1313 tax ID	*
[Ref.: #20218]	Streptococcus pneumoniae strain ATCC 49619 16S-23S ribosomal RNA intergenic spacer, partial sequence	EU860321	248	GenBank ENA	1313 tax ID	*
[Ref.: #124043]	Streptococcus pneumoniae strain ATCC 49619 16S ribosomal RNA gene, partial sequence.	OR501369	1410	GenBank ENA	1313 tax ID	*

Genome sequence information:

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Streptococcus pneumoniae ATCC 49619	GCA_003966485	complete	GenBank ENA	1313 tax ID	*
[Ref.: #66792]	Streptococcus pneumoniae strain ATCC 49619	1313.16298	complete	PATRIC	1313 tax ID	*

Data predicted using genome information as a basis Genome-based predictions

	Trait	Model	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Streptococcus pneumoniae ATCC 49619 NCBI: GCA_003966485.1
[Ref.: #69481]	spore-forming	spore-formingⓘ	no	100	no

	Trait	Model	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Streptococcus pneumoniae ATCC 49619 NCBI: GCA_003966485.1
[Ref.: #69480]	gram-positive	gram-positiveⓘ	yes	89.656	no
[Ref.: #69480]	anaerobic	anaerobicⓘ	no	87.578	no
[Ref.: #69480]	aerobic	aerobicⓘ	no	97.763	no
[Ref.: #69480]	spore-forming	spore-formingⓘ	no	82.371	no
[Ref.: #69480]	thermophilic	thermophileⓘ	no	96	no
[Ref.: #69480]	flagellated	motile2+ⓘ	no	90.479	no

Availability in culture collections External links

[Ref.: #17316]

Culture collection no.

DSM 24048, ATCC 49619, CCM 4501, CCUG 33638, DSM 11967, LMG 15155, CIP 104340, NCTC 12977

[Ref.: #83867]

SI-ID 7827

Literature:

Only first 10 entries are displayed. Click here to see all.

Topic	Title	Authors	Journal	DOI	Year
Cultivation	Preservation of Streptococcus pneumoniae quality control strains using chocolate agar blocks in glycerol at minus 70 degrees celsius.	Chandrasingh S, Subramaniam M, Nair S	J Microbiol Methods	10.1016/j.mimet.2022.106469	2022	*
Pathogenicity	Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests.	Sabanci AU, Erkan Alkan P, Mujde C, Polat HU, Ornek Erguzeloglu C, Bisgin A, Ozakin C, Temel SG	Int J Nanomedicine	10.2147/IJN.S328090	2022	*
Pathogenicity	Equal adhesion to pneumocytes by pneumococci inducing bacteraemia and pneumonia.	Qu Y, Li M, Gao C, Zhang J, Luo X, Wang G, Jiang X, Yang J, Li X, Hu D, Zhu W, Shen W	J Pak Med Assoc	10.47391/JPMA.11-784	2022	*
Pathogenicity	In-laboratory quality control of nutrients for automatic bacteriology analyzer YUNON(R)Labstar 50.	Boronina LG, Samatova EV, Kukushkina MP, Panova SA, Ustyugova SS	Klin Lab Diagn	10.51620/0869-2084-2021-66-2-110-114	2021	*
Phylogeny	A New Phage Lysin Isolated from the Oral Microbiome Targeting Streptococcus pneumoniae.	van der Kamp I, Draper LA, Smith MK, Buttimer C, Ross RP, Hill C	Pharmaceuticals (Basel)	10.3390/ph13120478	2020	*
Cultivation	Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.	Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP	J Clin Microbiol	10.1128/JCM.00567-19	2019	*
Metabolism	Impact of different Streptococcus pneumoniae on the secretion of interleukin and adhesin from THP-1 monocytes.	Ren P, Zhang J, Yu L, Qu Y, Jiang X, Zhou Y, Hu D, Gao C	J Clin Lab Anal	10.1002/jcla.22927	2019	*
Genetics	Complete Genome Sequences of Streptococcus pneumoniae Strains HU-OH (Serotype 3, Sequence Type 183 [ST183]), NU83127 (Serotype 4, ST246), and ATCC 49619 (Serotype 19F, ST1203).	Nagaoka K, Konno S, Murase K, Kikuchi T, Morinaga Y, Yanagihara K, Nakagawa I	Microbiol Resour Announc	10.1128/MRA.01504-18	2019	*
Enzymology	Chemical constituents from leaves and trunk bark of Rinorea oblongifolia (Violaceae).	Munvera AM, Ouahouo BMW, Mkounga P, Mbekou MIK, Nuzhat S, Choudhary MI, Nkengfack AE	Nat Prod Res	10.1080/14786419.2019.1573230	2019	*
Metabolism	Gene expression analysis in the potent bactericidal activity of sitafloxacin against Streptococcus pneumoniae.	Kobayashi I, Kanesaka I, Kanayama Katsuse A, Takahashi H, Okumura R, Nakanishi Y, Kaneko A	J Infect Chemother	10.1016/j.jiac.2018.09.012	2018	*
Pathogenicity	Synthesis and evaluation of biological activity of benzoxaborole derivatives of azithromycin.	Tevyashova AN, Korolev AM, Mirchink EP, Isakova EB, Osterman IA	J Antibiot (Tokyo)	10.1038/s41429-018-0107-2	2018	*
Pathogenicity	In search of a counter you can count on: relative efficacy of human visual and automated colony counting.	Young LM, Rieman DJ, Walden L, Motz VA	Lett Appl Microbiol	10.1111/lam.12851	2018	*
Pathogenicity	Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.	Hackel MA, Karlowsky JA, Dressel D, Sahm DF	J Clin Microbiol	10.1128/JCM.00972-17	2017	*
Pathogenicity	Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures.	Miller N, Brassinne L, Allemeersch D	Acta Clin Belg	10.1080/17843286.2017.1331618	2017	*
Pathogenicity	Shin'iseihaito (Xinyiqingfeitang) Suppresses the Biofilm Formation of Streptococcus pneumoniae In Vitro.	Minami M, Konishi T, Takase H, Makino T	Biomed Res Int	10.1155/2017/4575709	2017	*
Enzymology	Experimental and In-Silico Investigation of Anti-Microbial Activity of 1-Chloro-2-Isocyanatoethane Derivatives of Thiomorpholine, Piperazine and Morpholine.	Nwuche CO, Ujam OT, Ibezim A, Ujam IB	PLoS One	10.1371/journal.pone.0170150	2017	*
Pathogenicity	Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014).	Ceyssens PJ, Van Bambeke F, Mattheus W, Bertrand S, Fux F, Van Bossuyt E, Damee S, Nyssen HJ, De Craeye S, Verhaegen J, Tulkens PM, Vanhoof R	PLoS One	10.1371/journal.pone.0154816	2016	*
Pathogenicity	Ceftaroline activity on certain respiratory tract and wound infection agents at the minimum inhibitory concentration level.	Yanik K, Guluzade E, Bilgin K, Karadag A, Eroglu C, Birinci A, Gunaydin M	J Infect Dev Ctries	10.3855/jidc.6300	2015	*
Metabolism	In vitro expression of Streptococcus pneumoniae ply gene in human monocytes and pneumocytes.	Hu DK, Liu Y, Li XY, Qu Y	Eur J Med Res	10.1186/s40001-015-0142-4	2015	*
Pathogenicity	Modulation of the activity of moxifloxacin and solithromycin in an in vitro pharmacodynamic model of Streptococcus pneumoniae naive and induced biofilms.	Vandevelde NM, Tulkens PM, Muccioli GG, Van Bambeke F	J Antimicrob Chemother	10.1093/jac/dkv032	2015	*
Pathogenicity	Helichrysum arenarium subsp. arenarium: phenolic composition and antibacterial activity against lower respiratory tract pathogens.	Gradinaru AC, Silion M, Trifan A, Miron A, Aprotosoaie AC	Nat Prod Res	10.1080/14786419.2014.924931	2014	*
Pathogenicity	Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method.	Ross JE, Mendes RE, Jones RN	J Clin Microbiol	10.1128/JCM.01210-14	2014	*
Pathogenicity	Determination of disk diffusion and MIC quality control guidelines for GSK2140944, a novel bacterial type II topoisomerase inhibitor antimicrobial agent.	Ross JE, Scangarella-Oman NE, Flamm RK, Jones RN	J Clin Microbiol	10.1128/JCM.00656-14	2014	*
Phylogeny	[Molecular-genetic and phylogenetic characteristic of Streptococcus pneumoniae strains isolated from patients with meningitis and carriers].	Aleshkin VA, Karaulov AV, Slobodeniuk VV, Afanas'ev SS, Urban IuN, Voropaeva EA, Afanas'ev MS, Egorova EA, Metel'skaia VA, Aleshkin AV, Grechishnikova OG, Bairakova AL, Nesvizhskii IuV, Rubal'skii EO	Zh Mikrobiol Epidemiol Immunobiol		2013	*
Pathogenicity	Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model.	Vandevelde NM, Tulkens PM, Van Bambeke F	Antimicrob Agents Chemother	10.1128/AAC.01858-13	2013	*
Metabolism	Effects of clinical isolates of Streptococcus pneumoniae on THP-1 human monocytic cells.	Zhang J, Hu DK, Wang DG, Liu Y, Liu CB, Yu LH, Qu Y, Luo XH, Yang JH, Yu J, Liu SC, Li XY	Mol Med Rep	10.3892/mmr.2013.1688	2013	*
Pathogenicity	Detection of Streptococcus pneumoniae from Different Types of Nasopharyngeal Swabs in Children.	Dube FS, Kaba M, Whittaker E, Zar HJ, Nicol MP	PLoS One	10.1371/journal.pone.0068097	2013	*
Pathogenicity	In vitro inflammatory responses elicited by isolates of Alloiococcus otitidis obtained from children with otitis media with effusion.	Ashhurst-Smith C, Hall ST, Burns CJ, Stuart J, Blackwell CC	Innate Immun	10.1177/1753425913492181	2013	*
Pathogenicity	Rapid bactericidal activity of sitafloxacin against Streptococcus pneumoniae.	Kanda H, Inoue K, Okumura R, Hoshino K	Jpn J Antibiot		2013	*
Metabolism	Roles of virulence genes (PsaA and CpsA) on the invasion of Streptococcus pneumoniae into blood system.	Hu DK, Wang DG, Liu Y, Liu CB, Yu LH, Qu Y, Luo XH, Yang JH, Yu J, Zhang J, Li XY	Eur J Med Res	10.1186/2047-783X-18-14	2013	*
Pathogenicity	Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial.	Ross JE, Scangarella-Oman N, Jones RN	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2013.01.007	2013	*
Pathogenicity	Antimicrobial susceptibility testing of Streptococcus pneumoniae and Haemophilus influenzae --internal quality control as a quality tool on a national level.	Karpanoja P, Nissinen A, Huovinen P, Sarkkinen H	APMIS	10.1111/apm.12021	2012	*
Pathogenicity	Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.	Ross JE, Sader HS, Ivezic-Schoenfeld Z, Paukner S, Jones RN	J Clin Microbiol	10.1128/JCM.01294-12	2012	*
Pathogenicity	Evaluation of silicon oil on bacterial growth.	Adams F, Romero IL, Silva CB, Manzano RP	Arq Bras Oftalmol	10.1590/s0004-27492012000200003	2012	*
Pathogenicity	An Escherichia coli cell membrane chromatography-offline LC-TOF-MS method for screening and identifying antimicrobial peptides from Jatropha curcas meal protein isolate hydrolysates.	Xiao J, Zhang H	J Biomol Screen	10.1177/1087057112442744	2012	*
Pathogenicity	Synthesis, antimicrobial and antiproliferative activity of novel silver(I) tris(pyrazolyl)methanesulfonate and 1,3,5-triaza-7-phosphadamantane complexes.	Pettinari C, Marchetti F, Lupidi G, Quassinti L, Bramucci M, Petrelli D, Vitali LA, da Silva MF, Martins LM, Smolenski P, Pombeiro AJ	Inorg Chem	10.1021/ic201714c	2011	*
Pathogenicity	Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.	Ross JE, Scangarella-Oman NE, Miller LA, Sader HS, Jones RN	J Clin Microbiol	10.1128/JCM.01213-11	2011	*
Pathogenicity	Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone.	Ross JE, Liverman LC, Jones RN	J Clin Microbiol	10.1128/JCM.00636-11	2011	*
Phylogeny	[Bacterial strains isolated from systemic infections and reported for evaluation and antibiotic resistance surveillance by the "Dr. Victor Babes" Clinical Hospital for Infectious and Tropical Diseases, Bucharest].	Nica M, Biolan T, Dascalu A, Mozes E, Toderan A, Calistru P, Ceausu E	Bacteriol Virusol Parazitol Epidemiol		2010	*
Metabolism	Synthesis and antibacterial activity of novel 4''-O-benzimidazolyl clarithromycin derivatives.	Cong C, Wang H, Hu Y, Liu C, Ma S, Li X, Cao J, Ma S	Eur J Med Chem	10.1016/j.ejmech.2011.04.004	2011	*
Enzymology	Efficient screening of a novel antimicrobial peptide from Jatropha curcas by cell membrane affinity chromatography.	Xiao J, Zhang H, Niu L, Wang X	J Agric Food Chem	10.1021/jf103876b	2011	*
Metabolism	Olfactory ensheathing cells as putative host cells for Streptococcus pneumoniae: evidence of bacterial invasion via mannose receptor-mediated endocytosis.	Macedo-Ramos H, Campos FS, Carvalho LA, Ramos IB, Teixeira LM, De Souza W, Cavalcante LA, Baetas-da-Cruz W	Neurosci Res	10.1016/j.neures.2010.12.015	2010	*
Pathogenicity	Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives.	Qi Y, Jiao B, Ma X, Cui W, Ma S	Arch Pharm (Weinheim)	10.1002/ardp.200900288	2010	*
Pathogenicity	Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones.	Tomasic T, Zidar N, Mueller-Premru M, Kikelj D, Masic LP	Eur J Med Chem	10.1016/j.ejmech.2009.12.030	2009	*
Pathogenicity	Different application volumes of ethyl-cyanoacrylate tissue adhesive can change its antibacterial effects against ocular pathogens in vitro.	Romero IL, Paiato TP, Silva CB, Nigro JB, Malta S, Jenne Mimica LM, Soong HK, Hida RY	Curr Eye Res	10.1080/02713680802437692	2008	*
Pathogenicity	Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters.	Arhin FF, Tomfohrde K, Draghi DC, Aranza M, Parr TR Jr, Sahm DF, Moeck G	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2008.05.009	2008	*
Enzymology	Streptococcus pneumoniae adherence in rats under different degrees and durations of cigarette smoke.	Ozlu T, Celik I, Oztuna F, Bulbul Y, Ozsu S	Respiration	10.1159/000112472	2007	*
Enzymology	[Species-identification and antimicrobial susceptibility tests by the fully automated RAISUS using an early-harvested cell suspension].	Nakasone I, Kisanuki K, Higa M, Kinjo T, Yamane N	Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi		2006	*
Pathogenicity	Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.	Rennie RP, Koeth L, Jones RN, Fritsche TR, Knapp CC, Killian SB, Goldstein BP	J Clin Microbiol	10.1128/JCM.02411-06	2007	*
Cultivation	Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.	Brown SD, Traczewski MM	J Clin Microbiol	10.1128/JCM.02351-06	2007	*
Pathogenicity	Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)-methyl]piperazine.	Narendra Sharath Chandra JN, Sadashiva CT, Kavitha CV, Rangappa KS	Bioorg Med Chem	10.1016/j.bmc.2006.05.064	2006	*
Enzymology	Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in vitro model simulating serum concentration.	Fukuda Y, Takahata M, Mitsuyama J	J Infect Chemother	10.1007/s10156-005-0420-0	2006	*
Pathogenicity	Does cold environment affect Streptococcus pneumoniae adherence to rat buccal epithelium?	Oztuna F, Ozlu T, Bulbul Y, Buruk K, Topbas M	Respiration	10.1159/000090160	2005	*
Pathogenicity	[Study on the molecule epidemiological between resistances of 7 genes interrelated 4 antibiotic to isolated Streptococcus pneumoniae in children].	Ding YF, Mi ZH, Zhang JH, Tao YZ, Qin L	Zhonghua Liu Xing Bing Xue Za Zhi		2005	*
Pathogenicity	[Study on drug resistance and molecular epidemiology of Streptococcus pneumoniae isolated in Chongqing].	Yao C, Yu ZB, Xiao YH	Zhonghua Liu Xing Bing Xue Za Zhi		2005	*
Pathogenicity	Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin.	Bouchillon SK, Johnson JL, Hoban DJ, Stevens TM, Johnson BM	J Antimicrob Chemother	10.1093/jac/dki156	2005	*
Pathogenicity	Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.	Firsov AA, Alferova IV, Smirnova MV, Lubenko IY, Portnoy YA, Zinner SH	Int J Antimicrob Agents	10.1016/j.ijantimicag.2005.02.004	2005	*
Pathogenicity	[Study on the molecular epidemiology of beta-lactamase TEM gene in isolated Streptococcus pneumoniae].	Ding YF, Zhang JH, Mi ZH, Qin L, Tao YZ, Qi X	Zhonghua Liu Xing Bing Xue Za Zhi		2004	*
Pathogenicity	An ex-vivo pharmacodynamic study comparing bactericidal activity of amoxicillin/sulbactam, azithromycin, doxycycline and levofloxacin against Streptococcus pneumoniae.	Bantar C, Nicola F, Arenoso H, Soutric J, Caruso N, Fernandez Canigia L	J Chemother	10.1179/joc.2004.16.3.248	2004	*
Pathogenicity	Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor.	Anderegg TR, Jones RN	Diagn Microbiol Infect Dis	10.1016/S0732-8893(03)00162-7	2004	*
Enzymology	Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.	Zinner SH, Lubenko IY, Gilbert D, Simmons K, Zhao X, Drlica K, Firsov AA	J Antimicrob Chemother	10.1093/jac/dkg401	2003	*
Cultivation	Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.	Allen GP, Kaatz GW, Rybak MJ	Antimicrob Agents Chemother	10.1128/AAC.47.8.2606-2614.2003	2003	*
Pathogenicity	Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?	Deshpande LM, Jones RN	Diagn Microbiol Infect Dis	10.1016/s0732-8893(03)00050-6	2003	*
Pathogenicity	Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae.	Anderegg TR, Biedenbach DJ, Jones RN	Diagn Microbiol Infect Dis	10.1016/s0732-8893(03)00039-7	2003	*
Metabolism	Experimental pneumococcal pleural empyema model: the effect of moxifloxacin.	Strahilevitz J, Lev A, Levi I, Fridman E, Rubinstein E	J Antimicrob Chemother	10.1093/jac/dkg094	2003	*
Pathogenicity	Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone.	Anderegg TR, Jones RN	Diagn Microbiol Infect Dis	10.1016/s0732-8893(02)00482-0	2003	*
Enzymology	Influence of CO(2) incubation on quinolone activity against Streptococcus pneumoniae and Haemophilus influenzae.	Bolmstrom A, Karlsson A	Diagn Microbiol Infect Dis	10.1016/s0732-8893(01)00338-8	2002	*
Pathogenicity	Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.	Biedenbach DJ, Jones RN	Diagn Microbiol Infect Dis	10.1016/s0732-8893(01)00294-2	2001	*
Pathogenicity	Method preferences and test accuracy of antimicrobial susceptibility testing: updates from the College of Amercian Pathologists Microbiology Surveys Program.	Jones RN	Arch Pathol Lab Med	10.5858/2001-125-1285-MPATAO	2001	*
Enzymology	Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.	Margolis P, Hackbarth C, Lopez S, Maniar M, Wang W, Yuan Z, White R, Trias J	Antimicrob Agents Chemother	10.1128/AAC.45.9.2432-2435.2001	2001	*
Pathogenicity	Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001).	Jones RN, Biedenbach DJ	Diagn Microbiol Infect Dis	10.1016/s0732-8893(01)00236-x	2001	*
Pathogenicity	Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility tests.	Barry AL, Fuchs PC, Brown SD	J Antimicrob Chemother	10.1093/jac/48.1.121	2001	*
Pathogenicity	Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.	Tenover FC, Mohammed MJ, Stelling J, O'Brien T, Williams R	J Clin Microbiol	10.1128/JCM.39.1.241-250.2001	2001	*
Pathogenicity	Bactrim reduces the inflammatory response in a murine model of acute rhinosinusitis.	Won YS, Brichta A, Baroody F, Boonlayangoor S, Naclerio R	Rhinology		2000	*
Cultivation	Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media.	Marshall SA, Kugler KC, Jones RN	Int J Antimicrob Agents	10.1016/s0924-8579(00)00180-1	2000	*
Pathogenicity	Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.	Odland BA, Erwin ME, Jones RN	J Clin Microbiol	10.1128/JCM.38.1.453-455.2000	2000	*
Pathogenicity	Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group.	Jones RN, Johnson DM, Erwin ME, Beach ML, Biedenbach DJ, Pfaller MA	Diagn Microbiol Infect Dis	10.1016/s0732-8893(98)00085-6	1999	*
Pathogenicity	Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines.	Johnson DM, Jones RN, Erwin ME	Diagn Microbiol Infect Dis	10.1016/s0732-8893(98)00104-7	1999	*
Pathogenicity	Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group.	Marshall SA, Jones RN, Erwin ME	Diagn Microbiol Infect Dis	10.1016/s0732-8893(98)00105-9	1999	*
Pathogenicity	Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.	Jorgensen JH, Weigel LM, Ferraro MJ, Swenson JM, Tenover FC	Antimicrob Agents Chemother	10.1128/AAC.43.2.329	1999	*
Pathogenicity	A mouse model of acute bacterial rhinosinusitis.	Bomer K, Brichta A, Baroody F, Boonlayangoor S, Li X, Naclerio RM	Arch Otolaryngol Head Neck Surg	10.1001/archotol.124.11.1227	1998	*
Pathogenicity	Provisional quality control parameters and interpretive criteria for testing susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to quinupristin/dalfopristin (RP59500). Antimicrobial Testing Quality Control Group.	Fuchs P, Barry A, Brown S	Eur J Clin Microbiol Infect Dis	10.1007/BF01691118	1998	*
Pathogenicity	Microbiologic effect of bovine cerebrospinal fluid and azithromycin against Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae.	Destache CJ, Pakiz CB, Kersting K	Pharmacotherapy		1997	*
Phylogeny	In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/RPR106950): a novel orally administered streptogramin combination. The Quality Control Study Group.	Putnam SD, Jones RN, Johnson DM	Diagn Microbiol Infect Dis	10.1016/s0732-8893(97)00023-0	1997	*
Pathogenicity	Comparison of agar dilution, broth dilution, disk diffusion, and the E-test for susceptibility testing of penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.	Thorvilson J, Kohner P, Henry N, Cockerill F 3rd	Eur J Clin Microbiol Infect Dis	10.1007/BF01726371	1997	*
Pathogenicity	Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619.	Fuchs PC, Barry AL, Brown SD, Allen SD, Bauman M, Jorgensen JH, Tenover FC	Diagn Microbiol Infect Dis	10.1016/s0732-8893(97)89155-9	1997	*
Pathogenicity	Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.	Fuchs PC, Barry AL, Brown SD	J Clin Microbiol	10.1128/jcm.35.1.125-131.1997	1997	*
Pathogenicity	Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.	Jorgensen JH, Swenson JM, Tenover FC, Barry A, Ferraro MJ, Murray PR, Reller LB	J Clin Microbiol	10.1128/jcm.34.11.2679-2684.1996	1996	*
Pathogenicity	Discrepancies between results by E-test and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycin.	Hashemi FB, Schutze GE, Mason EO Jr	J Clin Microbiol	10.1128/jcm.34.6.1546-1547.1996	1996	*
Pathogenicity	In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits.	Barry AL, Fuchs PC, Allen SD, Brown SD, Jorgensen JH, Tenover FC	J Antimicrob Chemother	10.1093/jac/37.2.365	1996	*
Pathogenicity	Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methods.	Fuchs PC, Barry AL, Tenover FC, Allen SD, Jorgensen JH, Murray PR	J Antimicrob Chemother	10.1093/jac/36.5.781	1995	*
Pathogenicity	Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.	Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, Murray PR	J Clin Microbiol	10.1128/jcm.32.10.2448-2459.1994	1994	*
Pathogenicity	Testing of Streptococcus pneumoniae for resistance to penicillin.	Marshall KJ, Musher DM, Watson D, Mason EO Jr	J Clin Microbiol	10.1128/jcm.31.5.1246-1250.1993	1993	*
Pathogenicity	Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits.	Jorgensen JH, Doern GV, Ferraro MJ, Knapp CC, Swenson JM, Washington JA	J Clin Microbiol	10.1128/jcm.30.4.961-966.1992	1992	*
Pathogenicity	Assessment of the Anti-Inflammatory, Antibacterial and Anti-Aging Properties and Possible Use on the Skin of Hydrogels Containing Epilobium angustifolium L. Extracts.	Nowak A, Zagorska-Dziok M, Peruzynska M, Cybulska K, Kucharska E, Ossowicz-Rupniewska P, Piotrowska K, Duchnik W, Kucharski L, Sulikowski T, Drozdzik M, Klimowicz A	Front Pharmacol	10.3389/fphar.2022.896706	2022	*
	Probiotic Combination CBLEB Alleviates Streptococcus pneumoniae Infection Through Immune Regulation in Immunocompromised Rats.	Lv L, Peng L, Shi D, Shao L, Jiang H, Yan R	J Inflamm Res	10.2147/JIR.S348047	2022	*
	Psp140: an immunodominant antigen in the supernatant of Streptococcus pneumoniae culture.	Afshar D, Moghadam SO, Dehkordi FS, Ranjbar R, Hasanzadeh A	Iran J Microbiol	10.18502/ijm.v12i4.3938	2020	*
	Antibacterial Activity of Ritchiea albersii Gilg and Cynoglossum amplifolium Leaves Extracts against Selected Bacteria.	Engiso H, Worku T, Nureye D, Salahaddin M, Woldeselassie W, Hambisa S, Sharief N	Saudi J Med Med Sci	10.4103/sjmms.sjmms_276_19	2020	*
	Autolysin (lytA) recombinant protein: a potential target for developing vaccines against pneumococcal infections.	Afshar D, Rafiee F, Kheirandish M, Ohadian Moghadam S, Azarsa M	Clin Exp Vaccine Res	10.7774/cevr.2020.9.2.76	2020	*
	Antibacterial oral sprays from kaffir lime (Citrus hystrix DC.) fruit peel oil and leaf oil and their activities against respiratory tract pathogens.	Srifuengfung S, Bunyapraphatsara N, Satitpatipan V, Tribuddharat C, Junyaprasert VB, Tungrugsasut W, Srisukh V	J Tradit Complement Med	10.1016/j.jtcme.2019.09.003	2019	*
	CbpM and CbpG of Streptococcus Pneumoniae Elicit a High Protection in Mice Challenged with a Serotype 19F Pneumococcus.	Kazemian H, Afshar D, Garcia E, Pourmand MR, Jeddi-Tehrani M, Aminharati F, Shokri F, Yazdi MH	Iran J Allergy Asthma Immunol		2018	*
	Standardisation and evaluation of a quantitative multiplex real-time PCR assay for the rapid identification of Streptococcus pneumoniae.	Ganaie FA, Govindan V, Ravi Kumar KL	Pneumonia (Nathan)	10.15172/pneu.2015.6/559	2015	*
	In vivo efficacy of KRP-109, a novel elastase inhibitor, in a murine model of severe pneumococcal pneumonia.	Yamada K, Yanagihara K, Araki N, Harada Y, Morinaga Y, Izumikawa K, Kakeya H, Yamamoto Y, Hasegawa H, Kohno S, Kamihira S	Pulm Pharmacol Ther	10.1016/j.pupt.2011.08.001	2011	*
	Phenolic Secondary Metabolites and Antiradical and Antibacterial Activities of Different Extracts of Usnea barbata (L.) Weber ex F.H.Wigg from Calimani Mountains, Romania.	Popovici V, Bucur L, Gird CE, Popescu A, Matei E, Cozaru GC, Schroder V, Ozon EA, Fita AC, Lupuliasa D, Aschie M, Caraiane A, Botnarciuc M, Badea V	Pharmaceuticals (Basel)	10.3390/ph15070829	2022	*

References

#17316

Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 24048

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#41690 ; Curators of the CIP;
#51650 Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 33638

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#68380

Automatically annotated from API rID32A .

#68381

Automatically annotated from API rID32STR .

#68382

Automatically annotated from API zym .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#83867

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID7827.1 )

#121897 Collection of Institut Pasteur ; Curators of the CIP; CIP 104340

#124043

Dr. Isabel Schober, Dr. Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy .

* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Streptococcus pneumoniae in external resources:
SILVA
BRENDA
PANGAEA
GBIF

Streptococcus pneumoniae ATCC 49619

Streptococcus pneumoniae ATCC 49619

Change proposal

Change proposal